Overview of clinical studies and liposomal formulations of hamycin
Bhopale, G.M.
Hindustan Antibiotics Bulletin 49-50(1-4): 1-4
2007
ISSN/ISBN: 0018-1935 PMID: 19957536 Document Number: 607979
Hamycin, an antifungal agent, has been widely used for tropical applications in fungal infections of human. The present article briefly summarises its clinical studies, progress in the development of liposomal formulations and future research strategy in which both the clinicians and the scientists should be interested.
Document emailed within 1 workday
Related Documents
Cybulska, B.; Kupczyk, K.; Szlinder-Richert, J.; Borowski, E. 2002: Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME) Acta Biochimica Polonica 49(1): 67-75Naik, S.R.; Deshmukh, V.K.; Jalit, R.N.; Karnick, A.K. 1979: Further studies on anti-inflammatory activity of hamycin Hindustan Antibiotics Bulletin 22(1-2): 24-28
Golmohammadzadeh, S.; Jaafarixx, M.R.; Khalili, N. 2008: Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method Journal of Cosmetic Science 59(5): 385-398
Hanks, A.R. 2002: Committee on Pesticides and Disinfectant Formulations. Pesticide formulations: CIPAC studies. Collaborative International Pesticide Analytical Council Journal - Association of Official Analytical Chemists 85(1): 249-251
Muggia, F.M.; Rozencweig, M.; Chiuten, D.F.; Jensen-Akula, M.S.; Charles, L.M.; Kubota, T.T.; Bono, V.H. 1980: Phase Ii trials: use of a clinical tumor panel and overview of current resources and studies Cancer Treatment Reports 64(1): 1-9
Suyama, T.; Yokoyama, K.; Naito, R. 1981: Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients Progress in Clinical and Biological Research 55: 609-628
Kováč, I.; Gál, P.; Mojžiš, J.án. 2012: Phytotherapy of skin wounds - overview of experimental and clinical studies in the first decennium of the 21st century Casopis Lekaru Ceskych 151(9): 423-427
Ladhoff, A.M.; Koelsch, R.; Lasch, J. 1984: Incorporation of chemically modified (hydrophobized) ferritin in liposomal membranes: electron microscopic studies Biomedica Biochimica Acta 43(7): 963-969
Storb, R. 1994: Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center Bone Marrow Transplantation 14(Suppl 4): S1-S3
Giacoia, G.P.; Taylor-Zapata, P.; Mattison, D. 2007: Need for appropriate formulations for children: the national institute of child health and human development-pediatric formulations initiative, part 2 International journal of pharmaceutical compounding 11(3): 220-221
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Babras, M.A.; Suryavanshi, B.D.; Rajagopalan Nayar, P. 1979: Trial of hamycin in field outbreak of aspergillosis Hindustan Antibiotics Bulletin 22(1-2): 29-32
Thirumalachar, M.J.; Shende, G.Y. 1973: Hamycin in pulmonary mycoses--complicated tuberculosis Hindustan Antibiotics Bulletin 15(4): 141-144
Schall, R.; Luus, H.G. 1992: Comparison of absorption rates in bioequivalence studies of immediate release drug formulations International Journal of Clinical Pharmacology Therapy and Toxicology 30(5): 153-159
Trublin, F.; Robert, H.; Delcambre, B. 1980: Studies on the influence of uptake conditions on the bioavailability of different acid acetyl salicylic formulations Journal de Pharmacie de Belgique 62(6): 427-436
Daniele, B.; De Vivo, R.; Perrone, F.; Lastoria, S.; Tambaro, R.; Izzo, F.; Fiore, F.; Vallone, P.; Pignata, S. 2000: Phase i clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis Anticancer Research 20(2b): 1249-1251
Warowna-Grześkiewicz, M.; Chodkowski, J.; Fijałek, Z. 1995: Electrochemical studies of some quinolone antibiotics. Part II. Determination by differential pulse polarography in substance and in pharmaceutical formulations Acta Poloniae Pharmaceutica 52(6): 441-445
Thakre, R.P.; Johri, B.N. 1973: In vitro activity of aureofungin, amphotericin B and hamycin on the mycelial growth of some thermophilic fungi Hindustan Antibiotics Bulletin 15(3): 75-78
Rabin, R.L.; Slater, J.E.; Lachenbruch, P.; Pastor, R.W. 2003: Sample size considerations for establishing clinical bioequivalence of allergen formulations Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 94: 24-33
Larson, S.M. 1990: Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials Cancer research 50(3 Suppl): 892s-898s